BioShares Biotechnology Backtesting

BioShares Biotechnology Clinical Trials -- USA Etf  

USD 32.56  1.3  4.16%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of BioShares Biotechnology Clinical Trials and determine expected loss or profit from investing in BioShares Biotechnology over given investment horizon. Check also BioShares Biotechnology Hype Analysis, BioShares Biotechnology Correlation, Portfolio Optimization, BioShares Biotechnology Volatility as well as analyze BioShares Biotechnology Alpha and Beta and BioShares Biotechnology Performance
 Time Horizon     30 Days    Login   to change
SymbolX
Backtest

BioShares Biotechnology 'What if' Analysis

December 24, 2017
0.00
No Change 0.00  0.0%
In 30 days
January 23, 2018
0.00
If you would invest  0.00  in BioShares Biotechnology on December 24, 2017 and sell it all today you would earn a total of 0.00 from holding BioShares Biotechnology Clinical Trials or generate 0.0% return on investment in BioShares Biotechnology over 30 days. BioShares Biotechnology is related to or competes with Health Care, iShares Nasdaq, Vanguard Health, SPDR SP, iShares US, and iShares Global. The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of...

BioShares Biotechnology Upside/Downside Indicators

  

BioShares Biotechnology Market Premium Indicators

BioShares Biotechnology lagged returns against current returns

 Current and Lagged Values 
      Timeline 

BioShares Biotechnology regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

BioShares Biotechnology Backtested Returns

Macroaxis considers BioShares Biotechnology not too volatile given 1 month investment horizon. BioShares Biotechnology secures Sharpe Ratio (or Efficiency) of 0.3704 which signifies that BioShares Biotechnology had 0.3704% of return per unit of risk over the last 1 month. Our philosophy towards foreseeing volatility of a etf is to use all available market data together with company specific technical indicators that cannot be diversified away. By analyzing BioShares Biotechnology technical indicators you can presently evaluate if the expected return of 0.7116% is justified by implied risk. Please makes use of BioShares Biotechnology Downside Deviation of 2.04, Risk Adjusted Performance of 0.2018 and Mean Deviation of 1.42 to double-check if our risk estimates are consistent with your expectations. The organization shows Beta (market volatility) of -1.9319 which signifies that as returns on market increase, returns on owning BioShares Biotechnology are expected to decrease by larger amounts. On the other hand, during market turmoil, BioShares Biotechnology is expected to significantly outperform it.. Although it is vital to follow to BioShares Biotechnology historical returns, it is good to be conservative about what you can actually do with the information regarding equity current trending patterns. The philosophy towards foreseeing future performance of any etf is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. We have found twenty-one technical indicators for BioShares Biotechnology Clinical Trials which you can use to evaluate performance of the entity.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.26 

Poor predictability

BioShares Biotechnology Clinical Trials has poor predictability. Overlapping area represents the amount of predictability between BioShares Biotechnology time series from December 24, 2017 to January 8, 2018 and January 8, 2018 to January 23, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioShares Biotechnology price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current BioShares Biotechnology price fluctuation can be explain by its past prices.
Correlation Coefficient 0.26
Spearman Rank Test 0.43
Price Variance 0.56
Lagged Price Variance 0.28

BioShares Biotechnology Lagged Returns

 Regressed Prices 
      Timeline 

BioShares Biotechnology Performance vs DOW

The median price of BioShares Biotechnology for the period between Sun, Dec 24, 2017 and Tue, Jan 23, 2018 is 29.46 with a coefficient of variation of 4.5. The daily time series for the period is distributed with a sample standard deviation of 1.32, arithmetic mean of 29.47, and mean deviation of 1.06. The Etf received some media coverage during the period.
Price Growth (%)  
      Timeline 
1
BioShares Biotechnology Clinical Trials Rises 2.51 percent f...01/17/2018